MedTrace Logo

Early Digi-physical Support During Breastfeeding Initiation

NCT06044636 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 320

Last updated 2024-02-21

No results posted yet for this study

Summary

The purpose of this Randomized Controlled Trial is to develop and evaluate a digi-physical intervention within primary health care lactation counselling and breastfeeding support to promote exclusive breastfeeding rates during the first 6 months after birth and to prevent depressive symptoms.

The project addresses parents during pregnancy week 20 and 32 and will continue during the infant's first year of life. All participants will get access to an evidence-based information package (theory and practical advises) during pregnancy.

Study aim is to develop and evaluate digital evidence-based information materials and continuous support for both parents in order to increase prevalence of exclusive breastfeeding and duration as well as decreasing the risks of symptoms of post-partum depression.

Conditions

  • Breastfeeding
  • Self Efficacy
  • Breastfeeding Duration
  • Depression

Interventions

OTHER

Digi-physical breastfeeding support

* Breastfeeding support after birth is provided via chat * Extended home visits by a pediatric nurse after discharge from the maternity ward * Extra support from a lactation counselor when needed after discharge until one year after childbirth

Sponsors & Collaborators

Principal Investigators

  • Marina Taloyan, Associate Prof. · Region Stockholm

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-18
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06044636 on ClinicalTrials.gov